322M 12.5/1000 (Alogliptin Benzoate and Metformin Hydrochloride 12.5 mg / 1000 mg)
Pill with imprint 322M 12.5/1000 is Yellow, Elliptical / Oval and has been identified as Alogliptin Benzoate and Metformin Hydrochloride 12.5 mg / 1000 mg. It is supplied by Perrigo New York Inc..
Alogliptin/metformin is used in the treatment of diabetes, type 2 and belongs to the drug class antidiabetic combinations. There is no proven risk in humans during pregnancy. Alogliptin/metformin 12.5 mg / 1000 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for 322M 12.5/1000
Alogliptin Benzoate and Metformin Hydrochloride
- Imprint
- 322M 12.5/1000
- Strength
- 12.5 mg / 1000 mg
- Color
- Yellow
- Size
- 22.00 mm
- Shape
- Elliptical / Oval
- Availability
- Prescription only
- Drug Class
- Antidiabetic combinations
- Pregnancy Category
- B - No proven risk in humans
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Perrigo New York Inc.
- Inactive Ingredients
-
mannitol, microcrystalline cellulose, magnesium stearate, magnesium silicate, titanium dioxide, ferric oxide yellow, hypromellose 2910 (6 mPa.s)
Note: Inactive ingredients may vary.
Labelers / Repackagers
| NDC Code | Labeler / Repackager |
|---|---|
| 45802-0211 | Perrigo Company |
| 64764-0337 | Takeda Pharmaceutical Company Limited |
Related Images for "322M 12.5/1000"
More about alogliptin / metformin
- Side Effects
- During Pregnancy
- Dosage Information
- Imprints, Shape & Color Data
- Drug Interactions
- Pricing & Coupons
- En Español
- 1 Review
- Drug class: antidiabetic combinations
- FDA Alerts (4)
Consumer resources
Other brands: Kazano
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
